PPIDT00150
Drug Information
| Name | Obiltoxaximab |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB05336 |
| Type | biotech |
| Indication | Investigated for use/treatment in anthrax exposure, bacterial infection, crohn's disease, and graft versus host disease. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Solution | Intravenous |
100 mg / mL
|
| Solution | Intravenous |
100 mg/1mL
|
| Injection, solution, concentrate | Intravenous |
100 MG/ML
|